Candel Therapeutics, Inc. CADL Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s enterprise value?
- Candel Therapeutics, Inc. (CADL) reported enterprise value of $166.92M in Q1 2026.
- How has Candel Therapeutics, Inc.'s enterprise value changed year-over-year?
- Candel Therapeutics, Inc.'s enterprise value decreased by 10.1% year-over-year, from $185.63M to $166.92M.
- What is the long-term trend for Candel Therapeutics, Inc.'s enterprise value?
- Over 4 years (2021 to 2025), Candel Therapeutics, Inc.'s enterprise value has grown at a 8.0% compound annual growth rate (CAGR), from $142.28M to $193.36M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.